ES
MARKETS / NASDAQ / HCSG
NASDAQ · SERVICES-NURSING & PERSONAL CARE FACILITIES · LARGE CAP

Healthcare Services Group, Inc. HCSG

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY8 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$1.8B
▲ 7.1% vs FY2024
Dividend streak
8 yrs
Raised every year since 2018
EPS · FY25
$0.81
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
11.7%
Net margin · FY25
3.2%
Dividend coverage
0.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.8B
Revenue, FY2025 · full 18-year series below
Revenue Net income
0.81.62.41.80.12008201120142017202020232025
0.81.62.41.80.12016201920222025

3 cents of every revenue dollar became profit this year.

Per share
USD 0.81
Diluted EPS, FY2025
EPS Dividend
0.511.50.812008201120142017202020232025
0.511.50.812016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
11.7%
Return on equity, FY2025
ROE
816243211.7%2008201120142017202020232025
816243211.7%2016201920222025
Operating margin3.7%
Net margin3.2%
Return on assets7.4%

Each USD of equity produced 12 cents of profit this year.

Returned to shareholders
USD 61.6M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 61.6M
Share of profit104.3%
Consecutive raises8 years

USD 61.6M in buybacks — 104% of the year's profit, so the payout drew on cash built up earlier.

Growth
+0.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.8%
+0.9%
+2.5%
+5.9%
Net income
+19.9%
−9.8%
+0.2%
+3.7%
EPS, diluted
+20.8%
−9.3%
+0.1%
+3.1%
Dividend / share
+2.4%
+2.6%
+2.8%
Returned to shareholders
−0.9%
+0.3%
+1.8%
+3.0%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.07B
Shares outstanding, FY2025
0.070.072008201120142017202020232025
0.070.072016201920222025
Change, 5 years−6.6%
Change, 10 years−3.4%

The share count shrank 7% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 794.3M
total assets, end of FY2025
Total assetsUSD 794.3M
EquityUSD 510.2M
CashUSD 125.2M
Current ratio3.38×

Equity funds 64% of total assets.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
1.8
1.7
1.7
1.7
1.6
1.8
1.8
2.0
1.9
1.6
1.4
1.3
1.1
1.1
0.9
0.8
0.7
0.6
Operating income $B
0.1
0.1
0.1
0.0
0.1
0.1
0.1
·
·
·
·
·
·
·
·
·
·
·
EBITDA $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
·
·
·
·
·
·
·
·
·
·
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
0.81
0.53
0.52
0.46
0.65
1.32
0.87
1.12
1.19
1.05
0.80
0.31
0.67
0.65
0.56
0.51
0.46
0.40
Dividend / sh $
·
·
·
0.86
0.84
0.82
0.80
0.78
0.76
0.74
0.72
0.70
·
0.65
0.63
0.60
0.49
0.39
Payout %
·
0
0
185
128
62
91
68
63
69
89
225
99
100
111
114
106
94
ROE %
11.7
8.3
8.8
7.9
10.6
21.2
14.3
19.9
23.9
24.4
20.3
7.8
18.3
19.8
17.7
16.3
14.8
13.2
Shares out B
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
·
·
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
52 of 52
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed